International Clinical Trials Day will be celebrated around the world on 20 May 2013, marking the anniversary of what is regarded as the first clinical trial, carried out by James Lind in 1747.
The day aims to raise awareness of the importance of research to healthcare and highlights how partnerships between patients and healthcare practitioners are vital to high-quality, relevant research studies.
As part of celebrations for International Clinical Trials Day, NISCHR CRC has launched a new video aimed at researchers in Wales. It describes the support we can offer, with real-life examples of the way this support has made a difference to researchers.
Head to our NISCHR CRC YouTube Channel to watch the video.
Don’t forget that you can also now follow us on Twitter @NISCHR_CRC or through our Welsh language account @CRCcymraeg
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.